AzTrials
AzTrials

Compartment SyndromeNCT00921271

The Application of Near Infrared Spectroscopy (NIRS) in the Detection of Lower Limb Compartment Syndrome

An observational study of Compartment Syndrome, run by University Hospital Birmingham NHS Foundation Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to determine how infrared spectroscopy compares to continuous compartment pressure monitoring in the detection of compartment syndrome. Individuals meeting the study eligibility criteria will be identified at time of admission by the receiving Trauma and Orthopaedics Registrar who will be trained in… Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Compartment Syndrome
What is being tested?
Monitoring of StO2
Type of treatment
Medical device
How many people
120 participants
Where
1 siteUnited Kingdom
Study dates
Sep 2009to Apr 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All patients admitted to Selly Oak Hospital (Secondary care) meeting the study inclusion criteria.

Who may be able to join

  • Patients with one or more of the following injuries:
  • tibial fracture
  • crush injury/soft tissue injury to lower limb without fracture
  • pelvic fracture
  • major vascular injury below the aortic bifurcation
  • 2 or more long bone fractures
  • Any patient sustaining a traumatic injury with a base deficit ≥ 6 mEq/L within 12 hours of Hospital admission.
  • Any patient receiving ≥ 6 units packed red blood cells within 12 hours of hospital admission.

Who cannot join

  • Age ≤ 16 years are excluded by design, as all pediatric cases are managed at Birmingham Childrens Hospital. There is no upper age limit.
  • Bilateral lower limb amputees.
  • Individuals who have received methylene blue within the previous week or during the study period.
  • Patient refusal to participated in the trial.
  • In the case of incapacitated patients, refusal by the patient's relatives/representatives, or where no representative can be identified.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Selly Oak Hospital

    Birmingham, West Midlands, B29 6JD

Other trials in United Kingdom

About this study

This study aims to determine how infrared spectroscopy compares to continuous compartment pressure monitoring in the detection of compartment syndrome.

Individuals meeting the study eligibility criteria will be identified at time of admission by the receiving Trauma and Orthopaedics Registrar who will be trained in the study design and protocols.

Read more

Eligible individuals will be approached about participating in the study either at time of admission or shortly afterwards, either by the chief investigator or another doctor trained in the research protocol. Where the individual is unconscious or otherwise incapacitated, which is likely in many major trauma victims, inclusion in the study will be discussed with the patient's legal representative and/or family.

The consent process for the study will consist of having the study protocol explained by either the chief investigator, or another doctor trained in the study design. Patients will be allowed to read a participant information sheet, and permitted as much time as they require to decide if they wish to participate in the study. Verbal and written consent will be taken using a study specific consent form.

In the case of incapacitated patients, the study design will be explained to their relatives' legal representatives as appropriate and advice sought from them as to whether they know of any reason why the patient might object to participate in the study. Upon regain capacity consent will be sought from the patient for storage and analysis of their study data.

Once consented, the patient will undergo monitoring with both continuous compartment pressures, and NIRS measurements.

Recordings for both techniques will be taken each hour, as part of the patients normal observations, from the point of consent until 24 hours after their first operation. Where patients do not have an operation the total duration of monitoring will be 24 hours. The measurements will be taken by nursing staff who have received training in both techniques. The procedure for each technique is described below:

  1. Continuous compartment pressures will be recorded in the broken leg, in case of tibial fractures, in all other patients fitting the inclusion criteria measurements will be taken from both legs (as both legs are at risk of compartment syndrome). Compartment pressures will be recorded using a slit catheter technique. Insertion of the slit catheter will be performed by either the chief investigator or Orthopaedic Registrar who will have been trained in the technique. The slit catheter is inserted using a sterile technique - the skin over the front outer part of the leg is cleaned and a catheter inserted into the anterior muscle compartment at this point. The catheter should be sited at the approximate midpoint of the leg, although this can be adjusted up or down if this would lead to insertion into a fracture site. The catheter is secured with a sterile dressing and connected to a monitor from which recordings can be taken, the catheter can be left in place for the duration of the study with no need to re-site it unless it stops recording accurately. At the same time as compartment pressure measurements are taken the patient's blood pressure will be monitored and the 'Perfusion Pressure' for the leg calculated, where: Perfusion pressure = diastolic blood pressure - leg compartment pressure
  2. NIRS measurements will be taken with an the INVOS system, produced by Somentics. These measurements will be taken from both legs, the affected leg and other other leg used as a control for comparison. Where both legs are at risk measurements will be taken from both legs and the midpoint of the forearm used as a control.

The INVOS probe is a small adhesive patch that is stuck to the skin. The probe is sterile and will be attached using the same sterile technique as the compartment pressure catheter. Where the overlying skin is hairy the hair overlying the area for the probe should be clipped before attaching the probe, to ensure adequate adhesion and accurate readings. The probe is to be sited just below the compartment pressure catheter, although if there is an underlying haematoma (blood clot), then the probe should be positioned so at to avoid this but still remaining over the front outer part of the leg. This technique conforms with the manufacturers recommended use of the equipment and is similar protocol to previous studies.

At the end of the monitoring period both measuring devices are removed. If the patient has developed compartment syndrome during this period and required an operation, the NIRS probe and compartment pressure catheter will be replaced for a further 12 hours of monitoring to monitor the changes post-operatively and ensure compartment pressures stay low.

Being tested
Monitoring of StO2
Keywords
Compartment syndrome
Medical subject headings
Compartment Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Monitoring of StO2Device

    Also called INOVOS system.

    Monitoring of lower limb anterior compartment StO2, taking measurements on an hourly basis for the duration of the study protocol.

Study groups in NCT00921271
Study groupRoleWhat they receive
At risk for compartment syndrome.Patients admitted to Selly Oak Hospital, Birmingham, Uk, meeting one or more of the following inclusion criteria: 1. Patients with one or more of the following injuries: * tibial fracture. * crush injury/soft tissue injury to lower limb without fracture. * pelvic fracture. * major vascular injury below the aortic bifurcation. * 2 or more long bone fractures. 2. Any patient sustaining a traumatic injury with a base deficit ≥ 6 mEq/L within 12 hours of Hospital admission. 3. Any patient receiving ≥ 6 units packed red blood cells within 12 hours of hospital admission.
Receives: Device: Monitoring of StO2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Absolute limb StO2 at limb perfusion pressures ≤ 30 mmHg.

    Measured: Hourly

  2. Control corrected limb StO2 at limb perfusion pressures ≤ 30 mmHg.

    Measured: Hourly

Secondary outcomes (4)
  1. Correlation between absolute limb StO2 and limb perfusion pressures.

    Measured: Hourly

  2. Correlation between control corrected limb StO2 and limb perfusion pressures.

    Measured: Hourly

  3. Incidence of compartment syndrome in study population.

    Measured: 24 hours

  4. Survival to discharge.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2009 (estimated)
  2. Study startSep 2009
  3. Primary completionApr 2011
  4. Study completionApr 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00921271
Sponsor's protocol ID
RRK3786
Status last verified
Sep 2011
First submitted
15 Jun 2009
Last updated
21 Sep 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Compartment Syndrome, run by University Hospital Birmingham NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Absolute limb StO2 at limb perfusion pressures ≤ 30 mmHg. (time frame: Hourly). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in